Tafenoquine-d3 Succinate
实时
已添加到 RFQ
仅供研究与分析用途。不可个人使用。
包装与处理
所示为供视觉参考的示意性产品包装。实际包装可能因包装规格、数量、储存条件和运输要求而异。
可提供文档
可应要求提供详细规格、证书和支持性文件。
可应要求提供详细规格、证书和支持性文件。
储存： 完整信息请参阅 MSDS。
危害： 完整信息请参阅 MSDS。
Tafenoquine-d3 Succinate 产品信息
Tafenoquine-d3 Succinate 归类于 Stable Isotopes，用于分析研究、质量控制和药物对照品应用。 本产品由 Clearsynth 提供，目录号为 CS-T-99826.
Clearsynth 提供该化合物用于研究和分析用途，产品信息包括 CAS 号、分子式、分子量和产品咨询详情。
技术数据
产品名称
Tafenoquine-d3 Succinate
CAT 编号
CS-T-99826
HSN 代码
38229010
原产国
Can be shipped from India, Canada and USA
分子式
C28H31D3F3N3O7
分子量
584.6
储存条件
完整信息请参阅 MSDS。
危险化合物
完整信息请参阅 MSDS。
描述
法规说明
Tafenoquine-d3 Succinate is supplied with detailed characterization data compliant with regulatory guideline. Tafenoquine-d3 Succinate can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
概述
"Tafenoquine-d3 Succinate is the labelled analog of Tatenoquine (T004760), a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the prevention and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase."
同义词
Tafenoquine-d3 Succinate
应用说明
"Tafenoquine-d3 Succinate is the labelled analog of Tatenoquine (T004760), a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the prevention and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase."
产品应用与法规搜索词
此参考标准的有用产品、供应商和法规搜索词。